» Articles » PMID: 23093730

Dramatic Increase in Cervical Cancer Registrations in Young Women in 2009 in England Unlikely to Be Due to the New Policy Not to Screen Women Aged 20-24

Overview
Journal J Med Screen
Specialty Public Health
Date 2012 Oct 25
PMID 23093730
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore whether the 17% increase in cervical cancer in England in 2009 was due to the change in cervical screening policy.

Methods: Trends in incidence of cervical cancer and of cervical intraepithelial neoplasia grade 3 (CIN3) were analysed for England, Wales and Scotland. Invasive cervical cancer data on 4079 cancers in women aged 20-39 diagnosed between April 2007 and August 2011 in England were analysed by single year of age.

Results: In England there was a 38% (95% confidence intervals [CI] 18-62%) increase in cervical cancer incidence rates in women aged 25-29 in 2009 relative to 2008, and a 30% (11-51%) increase in women aged 35-39. Compared rates in 2010 are similar to those in 2008. The average increase between 2000 and 2010 in women aged 25-29 was no greater in England than in Scotland and Wales (relative risk 0.98, 95% CI 0.69-1.39). In England there has been a gradual increase in CIN3 (particularly for ages 25-29) since 2003, with a more dramatic increase in 2009, but a fall in 2010. Audit data showed an increase in cancers diagnosed at age 25 in 2009/2010 and 2010/2011 (P ≤ 0.0004). No increase was observed at age 26. For ages 27-29 an increase in cancer was observed for 2008/2009-2009/2010 when compared with 2007/2008-2010/2011 (P < 0.00001), but linear trends were not significant.

Conclusions: The increase in cervical cancer in England in 2009 cannot be attributed to the lack of screening of women aged 20-24, or to a general decrease in the coverage or quality of cervical screening.

Citing Articles

Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells the posttranscriptional suppression of HGFR.

Shi F, Zhang Y, Wang J, Su J, Liu Z, Wang T RSC Adv. 2022; 9(39):22376-22383.

PMID: 35519460 PMC: 9066695. DOI: 10.1039/c9ra01785b.


Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.

Ngu S, Lau L, Li J, Wong G, Cheung A, Ngan H Int J Environ Res Public Health. 2022; 19(5).

PMID: 35270303 PMC: 8910259. DOI: 10.3390/ijerph19052610.


Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.

Gravdal B, Lonnberg S, Skare G, Sulo G, Bjorge T BMC Womens Health. 2021; 21(1):110.

PMID: 33736628 PMC: 7977265. DOI: 10.1186/s12905-021-01242-3.


Impact of screening on cervical cancer incidence in England: a time trend analysis.

Pesola F, Sasieni P BMJ Open. 2019; 9(1):e026292.

PMID: 30679300 PMC: 6347909. DOI: 10.1136/bmjopen-2018-026292.


Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Arbyn M, Smith S, Temin S, Sultana F, Castle P BMJ. 2018; 363:k4823.

PMID: 30518635 PMC: 6278587. DOI: 10.1136/bmj.k4823.